LONDON, Nov. 21, 2025 /PRNewswire/ — Meril Life Sciences today presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, a globally recognized structural heart […]
LONDON, Nov. 21, 2025 /PRNewswire/ — Meril Life Sciences today presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, a globally recognized structural heart […]
VAPI, Inde, 26 novembre 2024 /PRNewswire/ — Meril, leader mondial des solutions cardiovasculaires et cardiaques structurelles de pointe, est réputé pour ses technologies de valves cardiaques transcathéter de nouvelle génération. En poursuivant son engagement en […]
